| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1489464A Blood tipid amelipant composition |
| 04/14/2004 | CN1489463A Novel crystal forms of atorvastatin hemi-calcium and process for their preparation as well as novel process for preparing other forms |
| 04/14/2004 | CN1489462A Blood lipid ameliopant composition |
| 04/14/2004 | CN1489461A 甘油三酸酯降低剂组合物 Triglyceride lowering agent composition |
| 04/14/2004 | CN1488383A Medicine for treating hyperlipidemia |
| 04/14/2004 | CN1488381A Artichoke leaf cream extracting technique |
| 04/14/2004 | CN1488371A Chinses medicine oral preparation for treating diabete and preparing method thereof |
| 04/14/2004 | CN1488367A Taiwan lectuce herb-American ginseng capsule |
| 04/14/2004 | CN1488359A Magnesium-calcium ion composite preparation and production precess thereof |
| 04/14/2004 | CN1488344A Plant extract for preventing and treating diabetes, and preparing method and pharmaceutic use thereof |
| 04/14/2004 | CN1145641C Monomeric insulin analog formulations |
| 04/14/2004 | CN1145635C Glucopyranosyloxypyrazole derivatives, medicinal comopsitions containing the same and intermediates in the production |
| 04/14/2004 | CN1145625C Process for the production of tert-buty1 (E)-(6[2-[4-(4-fluorophenyl)-6-isopropyl-2[methyl(methyl sulfonyl)amino]pyrimidin5-yl](4R,65)-2,2-dimethyl[1,3]dioxan-4-yl]acetate ]) |
| 04/14/2004 | CN1145622C Substitated benzo heterocyclic compounds, process for their preparation and pharmaceutical compositions containing same |
| 04/14/2004 | CN1145619C 1-4-benzothiazepine derivatives methods for preparation, medicaments containing same and use thereof |
| 04/14/2004 | CN1145616C Novel amino-triazole compound, its preparation method and drug composition containing them |
| 04/14/2004 | CN1145615C Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 04/14/2004 | CN1145497C Enterogastric external nutrition composition and its pharmaceutic use thereof |
| 04/14/2004 | CN1145486C Pharmaceutical compositions containing eletriptan hemisulphate and coffeine |
| 04/13/2004 | US6720427 Used to treat abnormal cell growth and central nervous system disorders |
| 04/13/2004 | US6720351 1h-indole-2-carboxylic acid (2-(benzyl(methyl)amino) -2-oxo-1-phenylethyl)amides; triamide microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) inhibitors; obesity; antilipemic agents |
| 04/13/2004 | US6720348 For therapy of diabetic neuropathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic retinopathy, diabetic microangiopathy, diabetic macroangiopathy, cataracts and foot ulcers |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) |
| 04/13/2004 | US6720327 Lactone integrin antagonists |
| 04/13/2004 | US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | US6720316 Therapeutic 5-HT ligand compounds |
| 04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
| 04/13/2004 | CA2147123C Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
| 04/11/2004 | WO2004033703A1 Novel macrophage foam cell formation inhibitor fka-25 and process for producing the same |
| 04/11/2004 | CA2461942A1 Novel fka-25 substance having inhibitory action against formation of the foam macrophage and a process for production thereof |
| 04/08/2004 | WO2004029192A2 Producing method of tien hsien liquid |
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004028555A1 Resistin binding proteins, their preparation and use |
| 04/08/2004 | WO2004028554A2 Skrp, astray, string, vacm associated with metabolic control |
| 04/08/2004 | WO2004028546A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | WO2004028544A1 Use of mas-compounds for treating diseases associated with lipid metabolism |
| 04/08/2004 | WO2004028537A1 Use of thiazolidinedione derivatives as aldose reductase inhibitors |
| 04/08/2004 | WO2004028524A1 Combination drug |
| 04/08/2004 | WO2004028523A1 Particulate product comprising pantethine |
| 04/08/2004 | WO2004018468A3 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 04/08/2004 | WO2004016613A3 Purine derivatives and their use as antiproliferative agents |
| 04/08/2004 | WO2004014150A9 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 04/08/2004 | WO2004009124A3 Ghrelin-carrier conjugates |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003106452A3 Antagonists of melanin concentrating hormone receptor |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003104473A8 Galactosyl isomalt, method for production and use thereof |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003068732A3 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003057225A3 Phosphate transport inhibitors |
| 04/08/2004 | WO2003044037A3 Process for the manufacture of human mononuclear phagocytic leukocytes |
| 04/08/2004 | WO2003018606A9 Casein derived peptides and uses thereof in therapy |
| 04/08/2004 | WO2003018553A8 Oral antidiabetic agents |
| 04/08/2004 | WO2002090545A3 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |
| 04/08/2004 | WO2002081668A9 Desaturase genes and uses thereof |
| 04/08/2004 | US20040068268 Devices and methods for the restoration of a spinal disc |
| 04/08/2004 | US20040068123 Introduction of t-butyldimethylsilyl(TBDMS) group as an alcohol protection group and construction of deprotection reaction condition not to produce by-products promise highly pure production of simvastatin |
| 04/08/2004 | US20040068121 A key intermediate in the synthesis of atorvastatin calcium |
| 04/08/2004 | US20040068105 Plant thermogenic genes and proteins |
| 04/08/2004 | US20040068016 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 04/08/2004 | US20040068005 Pharmaceutical combinations |
| 04/08/2004 | US20040068001 Using hydroxy-3-methylglutaryl/3-/ coenzyme inhibitor |
| 04/08/2004 | US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 04/08/2004 | US20040067987 Antiarthritic agents; osteoporosis; anticancer agents |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067966 Adenosine receptor antagonists and methods of making and using the same |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067949 Substituted indoles which are parp inhibitors |
| 04/08/2004 | US20040067941 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 04/08/2004 | US20040067939 Indole-3-carboxamides as glucokinase activators |
| 04/08/2004 | US20040067933 Prevent bile acid transportation; antilipemic agents; anticholesterol agents |
| 04/08/2004 | US20040067921 Anticholesterol agents |
| 04/08/2004 | US20040067918 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 04/08/2004 | US20040067911 Antidiabetic agents; hypoglycemic agents |
| 04/08/2004 | US20040067888 Nucleic acid capable of binding to interferons |
| 04/08/2004 | US20040067872 Novel mono- and di-fluorinated benzothiepine compouds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 04/08/2004 | US20040067509 Method of identifying dna encoding physiologically active polypeptide in mammalian body |
| 04/08/2004 | US20040067500 Compositions and methods relating to the peroxisomal proliferator activated receptor-alpha mediated pathway |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067232 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 04/08/2004 | US20040067224 Enternal formulation |
| 04/08/2004 | US20040067215 Antiobestic agents and health foods |
| 04/08/2004 | DE202004000317U1 Medicine or food product comprises cinnamon powder formed into a tablet |
| 04/08/2004 | CA2500210A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | CA2498423A1 Combination drug |
| 04/07/2004 | EP1405862A2 Method for the identification of antigenic peptides |
| 04/07/2004 | EP1405861A2 Analogs of parathyroid hormone |
| 04/07/2004 | EP1405859A1 Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof and intermediate therefor |
| 04/07/2004 | EP1405848A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 04/07/2004 | EP1405636A1 Function regulator for retinoid relative receptor |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |